Stonepine Capital Management, LLC

Holdings History for CNS Pharmaceuticals, Inc. - Common Stock (CNSP)

Symbol: CNSP on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 48,827 shares
Security Ownership %: 7.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Stonepine Capital Management, LLC ownership in CNS Pharmaceuticals, Inc. Common Stock (CNSP)

13 Feb 2026 - Stonepine Capital Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 48,827 shares of CNS Pharmaceuticals, Inc. Common Stock (CNSP). This represents 7.9% ownership of the company. In their previous filing dated 04 Nov 2025, Stonepine Capital Management, LLC had reported owning 32,220 shares, indicating an increase of +52%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Stonepine Capital Management, LLC	7.9%	+38%	$288,079	48,827	+16,607	+52%	$5.90	13G/A	31 Dec 2025	13 Feb 2026, 17:02
Stonepine Capital Management, LLC	5.6%		$289,980	32,220			$9.00	13G	29 Oct 2025	04 Nov 2025, 12:19

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.2%	+0.2%	$256,342	48,827	+48,827	NEW	$5.25	Q4 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.